Regulatory inspections of interactive response technology systems have surged 140% since 2022, signaling intensified global scrutiny of data integrity, randomization, and system validation in clinical trials.
Justine Koor
Advertisement
Justine Koor, Director, Quality Assurance at IQVIA
Articles by Justine Koor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Control Plane for Agentic Clinical Operations: Governing Autonomous Digital Actors in Regulated Trials
2
HHS Launches SURPASS Program and Three Complementary Initiatives to Transform Clinical Trial Design and Infrastructure
3
Hierarchical Endpoints in Cardiology: How Much Treatment Benefit, and From Where
4
What ClinOps Professionals Just Starting With AI Should Keep Top of Mind
5